Guardant Health
GH
#2480
Rank
โ‚น502.95 B
Marketcap
โ‚น4,071
Share price
-5.93%
Change (1 day)
123.84%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น86.56 Billion

According to Guardant Health 's latest financial reports the company has โ‚น86.56 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Guardant Health - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น97.28 B16.26%
2022-12-31โ‚น83.67 B20.53%
2021-12-31โ‚น69.42 B-47.11%
2020-12-31โ‚น131.26 B252.1%
2019-12-31โ‚น37.28 B27.26%
2018-12-31โ‚น29.29 B107.3%
2017-12-31โ‚น14.13 B118.31%
2016-12-31โ‚น6.47 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น79.91 B-7.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น12.15 B-85.96%๐Ÿ‡บ๐Ÿ‡ธ USA